Meijuan Huang
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD19 chimeric antigen receptor T-cell therapy for the treatment of a patient with refractory Burkitt lymphoma after kidney transplant.
Journal: Cytotherapy
Published: June 02, 2025
Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 20, 2025
Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles.
Journal: Experimental hematology & oncology
Published: December 05, 2024
Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL.
Journal: Cancer immunology, immunotherapy : CII
Published: November 13, 2024
T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review.
Journal: Cell transplantation
Published: June 10, 2024
Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells.
Journal: International journal of nanomedicine
Published: October 05, 2022
Autophagy inhibitors enhance biomolecular delivery efficiency of extracellular vesicles.
Journal: Biochemical and biophysical research communications
Published: January 25, 2022
Fueling chimeric antigen receptor T cells with cytokines.
Journal: American journal of cancer research
Published: August 15, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026